LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 88

Search options

  1. Book: Diagnostik, Prognoseabschätzung und Therapie der myelodysplastischen Syndrome

    Nachtkamp, Kathrin / Rautenberg, Christina / Schröder, Thomas / Kündgen, Andrea / Germing, Ulrich

    (Refresher Onkologie ; 9, Nr. 3 (Oktober 2017))

    2017  

    Author's details Kathrin Nachtkamp, Christina Rautenberg, Thomas Schroeder, Andrea Kündgen, Ulrich Germing
    Series title Refresher Onkologie ; 9, Nr. 3 (Oktober 2017)
    Collection
    Language German
    Size Seite 27-39
    Publisher Thieme
    Publishing place Stuttgart
    Publishing country Germany
    Document type Book
    HBZ-ID HT019625217
    Database Catalogue ZB MED Medicine, Health

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Shelf markLoan statusLocation
    Zs A 6621 -9,3- verfügbar in Königswinter Königswinter

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  2. Book: Therapie mit Vidaza (Azacitidin)

    Kündgen, Andrea / Pleyer, Lisa / Pfeilstöcker, Michael

    die Rolle molekularer Marker in der Behandlung von MDS, Real-Life-Daten und Therapiemanagement

    (Thieme-Praxis-Report ; 7,9)

    2015  

    Author's details [Hrsg. und Autoren Andrea Kündgen ; Lisa Pleyer ; Michael Pfeilstöcker]
    Series title Thieme-Praxis-Report ; 7,9
    Collection
    Language German
    Size 11 S. : Ill., graph. Darst.
    Publisher Thieme
    Publishing place Stuttgart u.a.
    Publishing country Germany
    Document type Book
    HBZ-ID HT018745581
    Database Catalogue ZB MED Medicine, Health

    More links

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Shelf markLoan statusLocation
    Zs A 6809 -7,9- verfügbar in Königswinter Königswinter

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  3. Book ; Thesis: Methicillin resistente Staphylococcus aureus- Stämme im Großraum Köln

    Kündgen, Andrea

    eine Analyse des Zeitraums von 1984 bis 1999

    2007  

    Author's details vorgelegt von Andrea Kündgen, geb. Verhoeven
    Language German
    Size 97 S. : Ill., graph. Darst.
    Publishing country Germany
    Document type Book ; Thesis
    Thesis / German Habilitation thesis Köln, Univ., Diss., 2007
    HBZ-ID HT015278082
    Database Catalogue ZB MED Medicine, Health

    More links

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Shelf markLoan statusLocation
    2007 D 1008 order for loan Magazin

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  4. Article ; Online: The difficulty to define progression patterns in patients with early stage myelodysplastic syndromes and deletion 5q--new prognostic markers are needed.

    Kuendgen, Andrea

    Leukemia research

    2014  Volume 38, Issue 3, Page(s) 287–288

    MeSH term(s) Antineoplastic Agents/therapeutic use ; Biomarkers, Tumor/analysis ; Blood Transfusion ; Chromosome Deletion ; Chromosomes, Human, Pair 5 ; Disease Progression ; Humans ; Myelodysplastic Syndromes/diagnosis ; Myelodysplastic Syndromes/drug therapy ; Myelodysplastic Syndromes/genetics ; Myelodysplastic Syndromes/mortality ; Prognosis ; Survival Analysis ; Thalidomide/analogs & derivatives ; Thalidomide/therapeutic use
    Chemical Substances Antineoplastic Agents ; Biomarkers, Tumor ; Thalidomide (4Z8R6ORS6L) ; lenalidomide (F0P408N6V4)
    Language English
    Publishing date 2014-03
    Publishing country England
    Document type Editorial ; Research Support, Non-U.S. Gov't
    ZDB-ID 752396-8
    ISSN 1873-5835 ; 0145-2126
    ISSN (online) 1873-5835
    ISSN 0145-2126
    DOI 10.1016/j.leukres.2013.12.013
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Zs.A 1321: Show issues Location:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
    Jg. 1995 - 2021: Lesesall (1.OG)
    ab Jg. 2022: Lesesaal (EG)

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  5. Article: Hybrid or Mixed Myelodysplastic/Myeloproliferative Disorders - Epidemiological Features and Overview.

    Kuendgen, Andrea / Kasprzak, Annika / Germing, Ulrich

    Frontiers in oncology

    2021  Volume 11, Page(s) 778741

    Abstract: The WHO-category Myelodysplastic/Myeloproliferative neoplasms (MDS/MPNs) recognizes a unique group of clonal myeloid malignancies exhibiting overlapping features of myelodysplastic as well as myeloproliferative neoplasms. The group consists of chronic ... ...

    Abstract The WHO-category Myelodysplastic/Myeloproliferative neoplasms (MDS/MPNs) recognizes a unique group of clonal myeloid malignancies exhibiting overlapping features of myelodysplastic as well as myeloproliferative neoplasms. The group consists of chronic myelomonocytic leukemia (CMML), atypical chronic myeloid leukemia,
    Language English
    Publishing date 2021-11-16
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2649216-7
    ISSN 2234-943X
    ISSN 2234-943X
    DOI 10.3389/fonc.2021.778741
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  6. Article ; Online: An inexpensive way to treat elderly patients with high-risk MDS or AML.

    Kuendgen, Andrea

    Leukemia research

    2011  Volume 35, Issue 8, Page(s) 985–986

    MeSH term(s) Anemia, Refractory, with Excess of Blasts/drug therapy ; Anemia, Refractory, with Excess of Blasts/genetics ; Anemia, Refractory, with Excess of Blasts/pathology ; Anticonvulsants/therapeutic use ; Antimetabolites, Antineoplastic/therapeutic use ; Cytarabine/therapeutic use ; Humans ; Leukemia, Myeloid, Acute/drug therapy ; Leukemia, Myeloid, Acute/genetics ; Leukemia, Myeloid, Acute/pathology ; Neoplasm Recurrence, Local/drug therapy ; Neoplasm Recurrence, Local/genetics ; Neoplasm Recurrence, Local/pathology ; Remission Induction ; Treatment Outcome ; Valproic Acid/therapeutic use
    Chemical Substances Anticonvulsants ; Antimetabolites, Antineoplastic ; Cytarabine (04079A1RDZ) ; Valproic Acid (614OI1Z5WI)
    Language English
    Publishing date 2011-08
    Publishing country England
    Document type Comment ; Editorial
    ZDB-ID 752396-8
    ISSN 1873-5835 ; 0145-2126
    ISSN (online) 1873-5835
    ISSN 0145-2126
    DOI 10.1016/j.leukres.2011.03.026
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Zs.A 1321: Show issues Location:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
    Jg. 1995 - 2021: Lesesall (1.OG)
    ab Jg. 2022: Lesesaal (EG)

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  7. Article: Infectious Complications in Patients with Myelodysplastic Syndromes: A Report from the Düsseldorf MDS Registry.

    Kasprzak, Annika / Andresen, Julia / Nachtkamp, Kathrin / Kündgen, Andrea / Schulz, Felicitas / Strupp, Corinna / Kobbe, Guido / MacKenzie, Colin / Timm, Jörg / Dietrich, Sascha / Gattermann, Norbert / Germing, Ulrich

    Cancers

    2024  Volume 16, Issue 4

    Abstract: Despite notable advancements in infection prevention and treatment, individuals with hematologic malignancies still face the persistent threat of frequent and life-threatening complications. Those undergoing chemotherapy or other disease-modifying ... ...

    Abstract Despite notable advancements in infection prevention and treatment, individuals with hematologic malignancies still face the persistent threat of frequent and life-threatening complications. Those undergoing chemotherapy or other disease-modifying therapies are particularly vulnerable to developing infectious complications, increasing the risk of mortality. Myelodysplastic syndromes (MDS) predominantly affect the elderly, with the incidence rising with age and peaking at around 70 years. Patients with MDS commonly present with unexplained low blood-cell counts, primarily anemia, and often experience varying degrees of neutropenia as the disease progresses. In our subsequent retrospective study involving 1593 patients from the Düsseldorf MDS Registry, we aimed at outlining the incidence of infections in MDS patients and identifying factors contributing to heightened susceptibility to infectious complications in this population.
    Language English
    Publishing date 2024-02-16
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2527080-1
    ISSN 2072-6694
    ISSN 2072-6694
    DOI 10.3390/cancers16040808
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  8. Article ; Online: Is lenalidomide a new standard treatment for myelodysplastic syndrome?

    Kuendgen, Andrea

    Nature clinical practice. Oncology

    2007  Volume 4, Issue 7, Page(s) 396–397

    Language English
    Publishing date 2007-07
    Publishing country England
    Document type Comment ; Journal Article
    ZDB-ID 2173301-6
    ISSN 1743-4262 ; 1743-4254
    ISSN (online) 1743-4262
    ISSN 1743-4254
    DOI 10.1038/ncponc0823
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Zs.A 6029: Show issues Location:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
    ab Jg. 2022: Lesesaal (EG)

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  9. Article ; Online: Combining DNA methyltransferase and histone deacetylase inhibition to treat acute myeloid leukemia/myelodysplastic syndrome: achievements and challenges.

    Lübbert, Michael / Kuendgen, Andrea

    Cancer

    2015  Volume 121, Issue 4, Page(s) 498–501

    MeSH term(s) Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Azacitidine/administration & dosage ; Azacitidine/analogs & derivatives ; Clinical Trials as Topic ; DNA Modification Methylases/antagonists & inhibitors ; Drug Administration Schedule ; Enzyme Inhibitors/therapeutic use ; Histone Deacetylase Inhibitors/therapeutic use ; Humans ; Leukemia, Myeloid, Acute/drug therapy ; Leukemia, Myeloid, Acute/enzymology ; Myelodysplastic Syndromes/drug therapy ; Myelodysplastic Syndromes/enzymology ; Research Design ; Treatment Failure ; Valproic Acid/administration & dosage
    Chemical Substances Enzyme Inhibitors ; Histone Deacetylase Inhibitors ; Valproic Acid (614OI1Z5WI) ; decitabine (776B62CQ27) ; DNA Modification Methylases (EC 2.1.1.-) ; Azacitidine (M801H13NRU)
    Language English
    Publishing date 2015-02-15
    Publishing country United States
    Document type Editorial
    ZDB-ID 1429-1
    ISSN 1097-0142 ; 0008-543X ; 1934-662X
    ISSN (online) 1097-0142
    ISSN 0008-543X ; 1934-662X
    DOI 10.1002/cncr.29083
    Database MEDical Literature Analysis and Retrieval System OnLINE

    Full text online

    More links

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Uh III Zs.146: Show issues Location:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
    ab Jg. 2022: Lesesaal (EG)

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  10. Article ; Online: Novel therapies in low- and high-risk myelodysplastic syndrome.

    Germing, Ulrich / Schroeder, Thomas / Kaivers, Jennifer / Kündgen, Andrea / Kobbe, Guido / Gattermann, Norbert

    Expert review of hematology

    2019  Volume 12, Issue 10, Page(s) 893–908

    Abstract: ... ...

    Abstract Introduction
    MeSH term(s) Activin Receptors, Type II/therapeutic use ; Anemia/diagnosis ; Anemia/metabolism ; Anemia/pathology ; Anemia/therapy ; Antineoplastic Agents/therapeutic use ; Azacitidine/therapeutic use ; Bridged Bicyclo Compounds, Heterocyclic/therapeutic use ; Decitabine/therapeutic use ; Erythrocyte Transfusion/adverse effects ; Erythrocyte Transfusion/methods ; Hematinics/therapeutic use ; Humans ; Immunoglobulin Fc Fragments/therapeutic use ; Iron Chelating Agents/therapeutic use ; Lenalidomide/therapeutic use ; Myelodysplastic Syndromes/diagnosis ; Myelodysplastic Syndromes/metabolism ; Myelodysplastic Syndromes/pathology ; Myelodysplastic Syndromes/therapy ; Oligonucleotides/therapeutic use ; Prognosis ; Recombinant Fusion Proteins/therapeutic use ; Risk Assessment ; Stem Cell Transplantation ; Sulfonamides/therapeutic use ; Thalidomide/therapeutic use ; Thrombopoietin/therapeutic use ; Transplantation, Homologous
    Chemical Substances Antineoplastic Agents ; Bridged Bicyclo Compounds, Heterocyclic ; Hematinics ; Immunoglobulin Fc Fragments ; Iron Chelating Agents ; Oligonucleotides ; Recombinant Fusion Proteins ; Sulfonamides ; Thalidomide (4Z8R6ORS6L) ; Decitabine (776B62CQ27) ; Thrombopoietin (9014-42-0) ; luspatercept (AQK7UBA1LS) ; Activin Receptors, Type II (EC 2.7.11.30) ; Lenalidomide (F0P408N6V4) ; imetelstat (F60NE4XB53) ; Azacitidine (M801H13NRU) ; venetoclax (N54AIC43PW)
    Language English
    Publishing date 2019-07-31
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 2516804-6
    ISSN 1747-4094 ; 1747-4086
    ISSN (online) 1747-4094
    ISSN 1747-4086
    DOI 10.1080/17474086.2019.1647778
    Database MEDical Literature Analysis and Retrieval System OnLINE

    Full text online

    More links

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Zs.A 6943: Show issues Location:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
    ab Jg. 2022: Lesesaal (EG)

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

To top